Law360, New York (March 7, 2008, 12:00 AM EST) -- Wyeth is vowing to appeal after an Arkansas jury decided that it and Pfizer Inc. subsidiary Pharmacia & Upjohn Co. LLC should pay a combined $27.1 million in punitive damages in a case brought by a woman who says she developed breast cancer from the use of menopause drugs including Provera, Premarin and Prempro.
Wyeth said it would pursue post-trial motions and appeal the entire case if necessary. In February, a jury awarded plaintiff Donna Scroggin $2.75 million in compensatory damages.
Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.